PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New lymphoma treatment shows promise in dogs

New lymphoma treatment shows promise in dogs
2010-09-08
(Press-News.org) CHAMPAIGN, Ill. — Researchers have identified a new target for the treatment of lymphoma and are testing a potential new drug in pet dogs afflicted with the disease. At low doses, the compound, called S-PAC-1, arrested the growth of tumors in three of six dogs tested and induced partial remission in a fourth.

The results of the study, conducted by researchers at the University of Illinois, appear this month in the journal Cancer Research.



The new compound targets a cellular enzyme, procaspase-3, that when activated spurs a cascade of reactions that kill the cell, said chemistry professor Paul Hergenrother, who co-led the study with Tim Fan, a professor of veterinary clinical medicine.

Procaspase-3 offers an attractive target for cancer therapy, in part because cancers often interfere with normal cell death, and in part because many tumors – including those found in breast cancer, colon cancer, lung cancer, lymphoma, melanoma and liver cancer – contain high levels of procaspase-3.

"In my lab, we try to think of novel targets and novel approaches to cancer and other diseases," Hergenrother said. "We think about the pathways that lead to those diseases, and we try to intervene at spots where others have not."

The new compound is a modified version of a drug the researchers previously tested in mice and one dog.

The original compound, called PAC-1, was found to cause neurological excitation (neurotoxicity) even at low doses, the researchers said. Fan and his colleagues hypothesized that PAC-1, which works in part by grabbing zinc away from other molecules, was crossing the blood/brain barrier and latching onto zinc in the brain.

To prevent the compound from passing into the brain, Hergenrother's laboratory made a derivative of PAC-1 with an added chemical group, called a sulfonamide. Tests in pet dogs with spontaneously occurring lymphoma showed that the new compound, S-PAC-1, stabilized or reduced the size of tumors in a majority of the animals, without neurotoxicity. Other side effects were mild, and recent adjustments to the treatment protocol have minimized or eliminated them, the researchers report.

If S-PAC-1 proves to be effective and safe as a lymphoma treatment and is approved by the FDA for use in dogs and/or humans (a process that could take years, the researchers emphasized), it will likely be added to the arsenal of drugs already used to combat lymphoma in both dogs and humans. It could be used in combination with other drugs as a first treatment option or serve as a second line of defense if the cancer returns.

Cancer drug combinations must be carefully tailored to avoid "overlapping toxicities," Fan said, so a drug that effectively treats lymphoma with minimal side effects is very desirable.

The study in pet dogs is also unusual, Fan said, as most studies look at effects in mice and then, if a compound is promising and appears safe, it is tested in clinical trials in humans. The six dogs used in this study were veterinary patients that had spontaneously developed lymphoma, he said.

The similarities between human and canine lymphoma also add to the desirability of this approach, Hergenrother said.

"If you look at the genetic signatures of canine lymphoma and human lymphoma, they're very, very similar and their response to therapy is very, very similar," he said. "So there's lots of reasons to be optimistic about a compound that has some effect in the canines, that it could have a similar effect in humans."



INFORMATION:



This study was supported by funding from the National Cancer Institute at the National Institutes of Health. A new $525,000 grant from the NCI will support a clinical trial of S-PAC-1 in companion animal dogs.

More information about the upcoming trial is available online: http://vetmed.illinois.edu/vth/MedServices/SmallAnimal/CancerCareClinic/CancerCareClinic.html.

Editor's notes: To reach Paul Hergenrother, call 217-333-0363; e-mail hergenro@illinois.edu.

To reach Tim Fan, call 217-333-5375; e-mail t-fan@illinois.edu.

The paper, "Discovery and Canine Preclinical Assessment of a Nontoxic Procaspase-3-Activating Compound," is available from the U. of I. News Bureau.


[Attachments] See images for this press release:
New lymphoma treatment shows promise in dogs

ELSE PRESS RELEASES FROM THIS DATE:

Ghostwritten articles overstate benefits of hormone replacement therapy and downplay harms

2010-09-08
The first academic analysis of the 1500 documents unsealed in recent litigation against the pharmaceutical giant Wyeth (now part of Pfizer) reveals unprecedented insights into how pharmaceutical companies use ghostwriters to insert marketing messages into articles published in medical journals. Dr. Adriane Fugh-Berman, associate professor in the Department of Physiology at Georgetown University Medical Center in Washington DC, analyzed dozens of ghostwritten reviews and commentaries published in medical journals and journal supplements that were used to promote unproven ...

Quality measurement programs could shortchange physicians caring for at-risk patients

2010-09-08
Evaluating the quality of care delivered by individual physicians without accounting for such factors as their patients' socioeconomic status or insurance coverage risks undervaluing the work of those caring for a higher proportion of vulnerable patients. In the Sept. 8 Journal of the American Medical Association a team of Massachusetts General Hospital (MGH) researchers describe finding that primary care physicians' rankings on common quality measures appear to be associated with the characteristics of the patients they care for. Adjusting physician rankings based on ...

Sequencing the turkey genome

2010-09-08
An international consortium of researchers has completed the majority of the genome sequence of the domesticated turkey, publishing it in the online open-access journal PLoS Biology next week. In 2008, the research consortium set out to map the genetic blueprint for the domesticated turkey, the fourth-most popular source of meat in the United States. The complete genome sequence, rapidly acquired using 'next-generation' sequencing technology, promises new data for avian researchers and, ultimately, a better quality product for turkey producers and consumers. "To date, ...

Johns Hopkins researchers unravel clues to infertility among obese women

Johns Hopkins researchers unravel clues to infertility among obese women
2010-09-08
Obese women have a well-known risk for infertility, but a new Johns Hopkins Children's Center study has unraveled what investigators there believe is the mechanism that accounts for the risk. The research, conducted in mice and published online on Sept. 8 in the journal Cell Metabolism, shows that the pituitary gland actively responds to chronically high insulin levels, triggering a cascade of hormonal changes that disrupt ovarian function and impair fertility. The findings challenge the widely held belief that infertility is a result of insulin resistance — a body's ...

Compared to recent flu strains, 2009 H1N1 infection had lower risk of most serious complications

2010-09-08
An analysis of data from influenza cases in Wisconsin indicates individuals with 2009 H1N1 infections were younger than those with H3N2 (2007-2008), and that the risk of most serious complications was not higher in adults or children with 2009 H1N1 compared with recent seasonal strains, according to a study in the September 8 issue of JAMA. "The pandemic 2009 influenza A(H1N1) virus caused widespread transmission in the United States and other countries. The Centers for Disease Control and Prevention (CDC) estimates that 43 million to 89 million infections occurred in ...

Characteristics of patient panels appear associated with quality ratings of primary care physicians

2010-09-08
Patients panels (used to rate the quality of care of physicians) with greater proportions of underinsured, minority and non-English speaking patients were associated with lower physician quality rankings, according to a study in the September 8 issue of JAMA. Physicians have increasingly become the focus of quality performance measurement. Many health care systems now use physician clinical performance assessment as part of their re-credentialing process, and public reporting programs have become widely adopted approaches to influence clinician performance. "These programs ...

Dosing schedule of pneumococcal vaccine linked with increased risk of getting multiresistant strain

2010-09-08
Infants who received heptavalent pneumococcal conjugate vaccination (PCV-7) at 2, 4, and 11 months were more likely than unvaccinated controls to have nasopharyngeal (in the nasal passages and upper part of the throat behind the nose) acquisition of pneumococcal serotype 19A, a leading cause of respiratory pneumococcal disease, according to a study in the September 8 issue of JAMA. "A rapid increase in the presence of pneumococcal serotype 19A strains that are often multiresistant to antibiotics has been observed over the last decade. In the United States, serotype 19A ...

Fetal exposure to radiation and the risk of childhood cancer: What is the likelihood of a risk?

2010-09-08
Fetal exposure to radiation and the risk of childhood cancer: what is the likelihood of a risk? A new study published in this week's PLoS Medicine aims to evaluate the possibility that exposure of a fetus to computed tomography or radionuclide imaging performed during pregnancy might increase subsequent risk of childhood cancer. The researchers concluded that despite the very large size of their study they were unable to exclude the possibility of a very slight risk, and advise that beta hCG testing (blood pregnancy test) should continue to be done in all potentially ...

Regular statin use is associated with a reduced risk of developing rheumatoid arthritis

2010-09-08
There is an association between taking statins (lipid lowering drugs), and reduced risk of developing the chronic inflammatory disease, rheumatoid arthritis. These are the findings of a study by Gabriel Chodick and colleagues, published in this week's PLoS Medicine. The researchers conducted a retrospective cohort study among the 1.8-million members of Maccabi Healthcare Services (a health maintenance organization [HMO]) in Israel to identify adults who regularly took statins and did not have rheumatoid arthritis. Using Maccabi's large automated datasets, the researchers ...

Sexual health: Computer-based approaches increase knowledge

2010-09-08
Interactive computer packages are effective in improving knowledge about sexual health, according to a new study by Cochrane researchers. Computer-based approaches could help to tackle problems such as sexually transmitted infections and unwanted pregnancy. Patients may be unlikely to discuss sexual health concerns with health professionals because of the sensitivity of the issues, or simply because healthcare providers have limited time. Computer-based interventions are a promising alternative and have already proved successful in the promotion of HIV-related sexual ...

LAST 30 PRESS RELEASES:

Pavlov’s dogs were conditioned to go to their treat. Why do some animals learn to interact with the bell instead?

Call for Young Editorial Board members at Current Molecular Pharmacology

MSU team develops scalable climate solutions for agricultural carbon markets

Playing an instrument may protect against cognitive aging

UNM study finds link between Grand Canyon landslide and Meteor Crater impact

Ultra-hot Jupiter’s death spiral could reveal stellar secrets

You only get one brain! The best helmet material for protecting your noggin

Neurodegeneration and stroke after GLP-1RAs in diabetes and obesity

Pediatric COVID-19 hospitalization trends by race and ethnicity, 2020-2023

Research spotlight: New genetic roadmap offers insights into obesity and diabetes

Fred Hutch leads new Vanguard Study for Cancer Screening Research Network

‘Mismatched’ transplants now safe, effective for blood cancer patients, study finds

New research helps narrow down uncertainties in near-term precipitation projections for the Asian Water Tower

AI tool accurately detects tumor location on breast MRI

Researchers use OCT imaging to uncover how the fallopian tube transports embryos

PolyU secures RGC theme-based research scheme funding to develop cost-effective and sustainable Co-GenAI model

Van Andel Institute scientists develop technique for high-resolution single cell epigenetic analysis

The Lundquist Institute wins multi-year NIH grant exceeding $11 million to transform diagnosis and treatment of deadly mucormycosis

Review suggests ending adult boosters for tetanus, diphtheria

ESMT Berlin welcomes Rebecca Schaumberg to faculty

Blocking a little-known protein may offer new hope for devastating lung disease

Medieval medicine was smarter than you think – and weirdly similar to TikTok trends

FAU receives NIH grant to investigate amphetamine addiction

Realizing on-site carbon nanotube photo-thermoelectric imaging

Most of us love memes. But are they a form of comics?

Novel biosensor allows real-time monitoring of sucrose uptake in plants

Korea University researchers reveal revealing how WEE1 drives cancer resistance to immunotherapy

Pusan National University researchers develop breakthrough deep learning model that enhances handheld 3D medical imaging

SLAS Discovery and SLAS Technology demonstrate research impact with 2024 impact factors

Disease-causing bacteria can deal with stink as long as they get a meal

[Press-News.org] New lymphoma treatment shows promise in dogs